Marion McCourt Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Marion McCourt.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Marion McCourt. Marion McCourt is EVP Commercial in REGENERON PHARMACEUTICALS, INC. ($REGN) and SVP Commercial in REGENERON PHARMACEUTICALS INC ($REGN) and Chief Operating Officer in MEDIVATION, INC. ($MDVN) and Director in SCYNEXIS INC ($SCYX) and Director in CytomX Therapeutics, Inc. ($CTMX) and Principal Operating Officer in Axovant Sciences Ltd. ($AXON).
Latest Insider Trading Transactions of Marion McCourt
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CTMX, MDVN, REGN, SCYX, AXON
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 10 2021 | REGN | REGENERON PHARMACE ... | McCourt Marion | EVP Commercial | Option Exercise | M | 342.93 | 1,000 | 342,930 | 17,000 | |
| May 10 2021 | REGN | REGENERON PHARMACE ... | McCourt Marion | EVP Commercial | Sell | S | 495.63 | 1,000 | 495,630 | 17,038 | 18 K to 17 K (-5.54 %) |
| May 10 2021 | REGN | REGENERON PHARMACE ... | McCourt Marion | EVP Commercial | Buy | M | 342.93 | 1,000 | 342,930 | 18,038 | 17 K to 18 K (+5.87 %) |
| Dec 11 2020 | REGN | REGENERON PHARMACE ... | McCourt Marion | SVP Commercial | Option Exercise | A | 492.00 | 25,000 | 12,300,000 | 25,000 | |
| Dec 11 2020 | REGN | REGENERON PHARMACE ... | McCourt Marion | SVP Commercial | Grant | A | 0.00 | 2,000 | 0 | 17,038 | 15 K to 17 K (+13.30 %) |
| Dec 11 2020 | REGN | REGENERON PHARMACE ... | McCourt Marion | SVP Commercial | Grant | A | 0.00 | 1,075 | 0 | 15,038 | 14 K to 15 K (+7.70 %) |
| Oct 06 2020 | REGN | REGENERON PHARMACE ... | McCourt Marion | SVP Commercial | Option Exercise | M | 342.93 | 1,000 | 342,930 | 18,000 | |
| Oct 06 2020 | REGN | REGENERON PHARMACE ... | McCourt Marion | SVP Commercial | Option Exercise | M | 342.93 | 1,000 | 342,930 | 19,000 | |
| Oct 06 2020 | REGN | REGENERON PHARMACE ... | McCourt Marion | SVP Commercial | Sell | S | 600.00 | 1,000 | 600,000 | 13,963 | 15 K to 14 K (-6.68 %) |
| Oct 06 2020 | REGN | REGENERON PHARMACE ... | McCourt Marion | SVP Commercial | Buy | M | 342.93 | 1,000 | 342,930 | 14,963 | 14 K to 15 K (+7.16 %) |
| Oct 06 2020 | REGN | REGENERON PHARMACE ... | McCourt Marion | SVP Commercial | Sell | S | 612.15 | 1,000 | 612,150 | 13,963 | 15 K to 14 K (-6.68 %) |
| Oct 06 2020 | REGN | REGENERON PHARMACE ... | McCourt Marion | SVP Commercial | Buy | M | 342.93 | 1,000 | 342,930 | 14,963 | 14 K to 15 K (+7.16 %) |
| Dec 14 2018 | REGN | REGENERON PHARMACE ... | McCourt Marion | SVP Commercial | Option Exercise | A | 381.40 | 10,000 | 3,814,000 | 10,000 | |
| Dec 14 2018 | REGN | REGENERON PHARMACE ... | McCourt Marion | SVP Commercial | Grant | A | 0.00 | 10,000 | 0 | 12,500 | 2.5 K to 12.5 K (+400.00 %) |
| Jul 03 2018 | SCYX | SCYNEXIS INC | McCourt Marion | Director | Option Exercise | A | 1.69 | 9,217 | 15,577 | 9,217 | |
| Apr 04 2018 | SCYX | SCYNEXIS INC | McCourt Marion | Director | Option Exercise | A | 1.32 | 11,800 | 15,576 | 11,800 | |
| Feb 12 2018 | REGN | REGENERON PHARMACE ... | McCourt Marion | SVP Commercial | Option Exercise | A | 342.93 | 20,000 | 6,858,600 | 20,000 | |
| Feb 12 2018 | REGN | REGENERON PHARMACE ... | McCourt Marion | SVP Commercial | Grant | A | 0.00 | 2,500 | 0 | 2,500 | 0 to 2.5 K |
| Jan 04 2018 | SCYX | SCYNEXIS INC | McCourt Marion | Director | Option Exercise | A | 2.28 | 6,831 | 15,575 | 6,831 | |
| Jan 04 2018 | SCYX | SCYNEXIS INC | McCourt Marion | Director | Option Exercise | A | 2.28 | 19,989 | 45,575 | 19,989 | |
| Oct 04 2017 | SCYX | SCYNEXIS INC | McCourt Marion | Director | Option Exercise | A | 2.46 | 6,332 | 15,577 | 6,332 | |
| Jul 05 2017 | SCYX | SCYNEXIS INC | McCourt Marion | Director | Option Exercise | A | 1.83 | 8,511 | 15,575 | 8,511 | |
| Jun 22 2017 | CTMX | CytomX Therapeutic ... | McCourt Marion | Director | Option Exercise | A | 13.78 | 14,000 | 192,920 | 14,000 | |
| Apr 11 2017 | AXON | Axovant Sciences L ... | McCourt Marion | Principal Operating ... | Option Exercise | A | 15.13 | 465,000 | 7,035,450 | 465,000 | |
| Apr 04 2017 | SCYX | SCYNEXIS INC | McCourt Marion | Director | Option Exercise | A | 2.65 | 5,878 | 15,577 | 5,878 | |
| Mar 31 2017 | CTMX | CytomX Therapeutic ... | McCourt Marion | Director | Option Exercise | A | 17.00 | 28,000 | 476,000 | 28,000 | |
| Jan 27 2017 | SCYX | SCYNEXIS INC | McCourt Marion | Director | Option Exercise | A | 3.15 | 4,274 | 13,463 | 4,274 | |
| Jan 27 2017 | SCYX | SCYNEXIS INC | McCourt Marion | Director | Option Exercise | A | 3.15 | 34,144 | 107,554 | 34,144 | |
| Sep 30 2016 | MDVN | MEDIVATION, INC. | McCourt Marion | Chief Operating Off ... | Option Exercise | D | 31.58 | 80,905 | 2,554,980 | 0 | |
| Sep 30 2016 | MDVN | MEDIVATION, INC. | McCourt Marion | Chief Operating Off ... | Sell | D | 0.00 | 40,453 | 0 | 0 | 40.5 K to 0 (-100.00 %) |
| Sep 30 2016 | MDVN | MEDIVATION, INC. | McCourt Marion | Chief Operating Off ... | Sell | U | 0.00 | 541 | 0 | 0 | 541 to 0 (-100.00 %) |
| Feb 17 2016 | MDVN | MEDIVATION, INC. | McCourt Marion | Chief Operating Off ... | Option Exercise | A | 31.58 | 80,905 | 2,554,980 | 80,905 | |
| Feb 04 2016 | MDVN | MEDIVATION, INC. | McCourt Marion | Chief Operating Off ... | Grant | A | 0.00 | 40,453 | 0 | 40,453 | 0 to 40.5 K |
Page: 1